Out-licensing: Pharmaceutical/OTC/Non-Prescription & Gastrointestinal

Latest: Watch here for details of new products and services.

Our Products: Overview; Partnering Search; Company Profiling; Partneringtools; Reports; Partnering Consulting; Comparison
Forums: Visit our forums
Jobs: Visit our job site
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire New!
Contact us: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing Ltd
is a division of

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 1..6 of 6 - per page
Order by

Drug delivery systems

New Active Ingredient + Innovative Drug Delivery System = Business Success More

Lactofiltrum - double power prebiotic for improving intestinal microflora

Lactofiltrum is unique double-component product (lignin+lactulose) which combines prebiotic effect on normal intestinal microflora with neutralization of pathogenic bacteria More

Pancreatin

Pancreatin 10,000- 20,000 and 25,000 FIP- units of lipase per capsule More

Unique product for the treatment of Inflammatory Bowel Disease (Crohn's disease and Ulcerative collitis)

Unique product that is highly effective against IBD More

Medigreen: MIC-31- Gastric ulcer treatment

MIC-31 is a botanically derived potential drug candidate for gastric ulcer prevention and therapy. More

Unique product for the treatment of AAD and CDAD

New highly effecitve product for the treatment of Antibiotic Associated Diarrhea and more particular Clostridium difficile associated diarrhea More

Displaying 1..6 of 6 - per page
Order by

Your selection

Industry sector: Pharmaceutical del; OTC/Non-Prescription del
Therapeutic target: Gastrointestinal del

Browse By

Therapeutic target: Appendicitis; Cholangitis, sclerosing; Colitis; Colitis, ulcerative; Constipation; Crohn's disease; Diarrhea; Dyspepsia; Electrolyte replacement; Emesis; Emesis, motion; Esophagitis; Flatulence; Food poisoning; Gastritis; Gastroesophageal reflux disorder; Gastrointestinal (other); Gastrointestinal secretions; Gastroprokinetic; Helicobacter pylori; Inflammatory bowel disease; Irritable bowel syndrome; Nausea; Pancreatitis; Ulcer; Ulcer, gastric; Ulcer, gastroduodenal; Ulcer, peptic
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Maximizing Pharmaceutical Patent Lifecycles

Industry news: Pharmalicensing provides comprehensive industry coverage.

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us